Conclusion
In combination with TGCM, the new Evita-open-NEO HP can easily and
safely be implanted with minimal blood loss.
Conflict of Interest: Heinz Jakob is consultant to
JOTEC/CryoLife, former inventor and recipient of royalties until 2019;
Klaus Görlinger is the medical director of Tem Innovations GmbH, Munich,
Germany